Skip to content
Nicolas Biro, M.D.Oculoplastic Surgery
Request

Symptoms and Concerns

Eyelid Lesions and Reconstruction After Mohs

Evaluation and reconstructive planning for eyelid or periocular lesions, biopsy sites, and defects after skin-cancer removal.

Request ConsultationAll Symptoms

Why evaluation matters

One Symptom Can Have Different Contributors

A bump, sore, or changing area near the eye cannot be identified reliably from appearance alone. When skin cancer is diagnosed and removed, the remaining defect may involve skin, muscle, the eyelid margin, tear drainage structures, or deeper tissue. Reconstruction is planned around the final cleared defect and the need to protect the eye.

Possible contributors

  • Benign growths, cysts, or inflammatory lesions
  • Sun-related skin change or a lesion requiring biopsy
  • A planned Mohs procedure near the eyelid, brow, or cheek
  • A defect after biopsy, cancer excision, trauma, or prior reconstruction

When routine scheduling is not appropriate

A rapidly changing or bleeding lesion deserves timely medical assessment. Inability to close the eye, severe pain, significant trauma, or visual change requires more urgent evaluation.

Related Care Pathways

These procedure pages explain possible care pathways. The appropriate next step depends on the diagnosis, examination, goals, and urgency.

Eyelid Cancer and Mohs Reconstruction

Eyelid and periocular reconstruction after skin-cancer removal, planned to restore protection, closure, and contour.

What to know

Clinical references

See how sources, physician-review labels, and corrections are handled in the BiroMD content standards.

This page provides general education, not a diagnosis or treatment recommendation. Seek urgent care for sudden or severe eye, vision, or neurologic symptoms.

Your next step

Choose an Office for Oculoplastic Evaluation

Select the more convenient office, request an appointment through its official scheduling service, or call directly. The office confirms availability and visit details.